Emerging research suggest Retatrutide , a dual agonist targeting both GLP-1 and GIP , could provide a significant development for weight loss . Preliminary clinical tests have demonstrated impressive losses in visceral fat , potentially exceeding existing body composition treatments. However , additional assessment is necessary to fully determin… Read More